Support For Men With Advanced Prostate Cancer

Dendreon is committed to supporting men with advanced prostate cancer.

Support organizations

Below is a list of organizations that provide support and information for men with prostate cancer and their caregivers.

Contact these groups to start talking with other men with prostate cancer

ZERO—The Project to End Prostate Cancer
844-244-1309 or 202-463-9455
www.zerocancer.org
Visit site
UsTOO International
800-80-UsTOO or 630-795-1002
www.ustoo.org
Visit site

Other resources with information about prostate cancer and cancer in general

CancerCare
800-813-HOPE
www.cancercare.org
Visit site
National Coalition for Cancer Survivorship (NCCS)
877-NCCS-YES (877-622-7937)
www.canceradvocacy.org
Visit site
Cancer Support Community
202-659-9709
888-793-9355
www.cancersupportcommunity.org
Visit site
Prostate Conditions Education Council (PCEC)
866-477-6788
www.prostateconditions.org
Visit site
Malecare
212-673-4920
www.malecare.org
Visit site
Prostate Health Education Network (PHEN)
617-481-4020
www.prostatehealthed.org
Visit site
Men's Health Network
202-543-MHN-1 ext. 101
www.menshealthnetwork.org
Visit site
The Prostate Net
201-289-8221
www.theprostatenet.org
Visit site
National Association of State Prostate Cancer Coalitions
877-NASPCC-8
www.naspcc.org
Visit site
Women Against Prostate Cancer
202-580-5730
www.menshealthnetwork.org/wapc/about_us.php
Visit site
National Cancer Institute (NCI)
800-4-CANCER
www.cancer.gov
Visit site
National Cancer Institute: Prostate Cancer
800-4-CANCER
www.cancer.gov/cancertopics/types/prostate
Visit site

Professional societies

American Cancer Society (ACS)
800-ACS-2345
www.cancer.org
Visit site
American Society of Clinical Oncology (ASCO): People Living With Cancer
888-651-3038
571-483-1780
www.cancer.net
Visit site
American Urological Association (AUA)
800-828-7866
National Urology Health Hotline
www.urologyhealth.org
Visit site
National Comprehensive Cancer Network
215-690-0300
www.nccn.org
Visit site
PROVENGE & You

The first and only personalized immunotherapy for mCRPC.

Download
Share this page